3Koch E, Malek FA. Standardized extracts from hawthorn leaves and flowers in the treatment of cardiovascular disorders-preclinical and clinical studies. Planta Med, 2011,77 ( 11 ) : 1123-1128.
4Jiang G,Wang D, Li W, et al. Coronary heart disease mortality in China: age, gender, and urban-rural gaps during epidemiological transitiorL[ J ]. Rev Panam Salud Publiea,2012,31 ( 4 ) :317 - 324.
5Mukherjee D. ACP Journal Club. Review: enoxaparin during PCI is better than unfractionated heparin for reducing mortality in coro- nary heart disease[ J]. Ann Intern Med,2012,156(10) :C2 - C5.
6Boden WE. Mounting evidence for lack of PCI benefit in stable is- chemic heart disease:what more will it take to turn the tide of treat- ment:comment on "initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease" [J]. Arch Intern Med,2012,172(4) :319 -321.
7Takagi H, Matsui M, Umemoto T. High-density lipoprotein-depend-ent effects of statins on the risk of coronary heart disease deaths and events [ J ]. Int J Cardiol,2011,152 ( 3 ) :377 - 379.
8Danaei G, Rodriguez LA, Cantero OF,et al. Observational data for comparative effectiveness research : an emulation of randomised trials of statins and primary prevention of coronary heart disease[ J]. Stat Methods Med Res,2013,22(1) :70 -96.
9Parrinello G,Torres D,Paterna S,et al. Short-term walking physical training and changes in body hydration status, B - type natriuretic peptide and C -reactive protein levels in compensated congestive heart failure[J]. Int J Cardiol,2010.144( 1 ) :97 - 100.
10Liteplo AS, Marill KA, Villen T, et al. Emergency thoracic uhra- sound in the differentiation of the etiology of shortness of breath (ETUDES) : sonographic B - lines and N - terminal pro-brainJtype natriuretic peptide in diagnosing congestive heart failure[ J]. Acad Emerg Meal,2009,16(3) :201 -210.
